Our State of Florida grant with Drs. Jonathan Schatz (PI), Yangbo Feng, and Stephan Schuerer was selected for funding! The goal of this grant is to validate a novel drug target that we discovered for DLBCL lymphoma and to develop a drug candidate for this target.
Recent Posts
See AllOur grant application (Ali, Lemmon, Bixby, Lee, Arizala) to the Blueprint Neurotherapeutics network was selected for funding! The goal of this proposal is to generate a therapeutic candidate (spinal c
1910
We are moving full steam ahead with the pre-clinical development and IND enabling studies of our therapeutic candidate for spinal cord injury, with projected entry into a clinical trial by 2024/2025.
50
Our grant application (Ali, Lemmon, Bixby, Lee, Arizala) to the Blueprint Neurotherapeutics network was reviewed favorably. Central nervous system (CNS) axons typically fail to regenerate after injury
370